RxDoctor Payments Data

Tyler Vandyck, MD

Critical Care Medicine · Pittsburgh, PANPI 1104206358

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 53 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Abiomed at 26.5% of the total. Reporting peaked in 2023 at $1,283 and has fallen 51.5% since, to $622 in 2025.

$3,717in general payments, 2019–2025

Across 53 payments — averaging $70.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abiomed$987
  • Abbott$746
  • Medtronic$699
  • Getinge USA Sales, LLC$517
  • Johnson & Johnson$298
  • Michigan Critical Care Consultants, Inc.$126
  • plus $344 from 6 others

What the payments were for

  • Travel & lodging$10%
  • Food & beverage$3,716100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abiomed15$987
Abbott7$746
Medtronic6$699
Getinge USA Sales, LLC11$517
Johnson & Johnson(2 entities)4$298
Michigan Critical Care Consultants, Inc.1$126
La Jolla Pharmaceutical Company1$123
Heartflow, Inc.2$98
Haemonetics Corporation2$44
Livanova USA, Inc.2$29
Edwards Lifesciences1$26
BD1$24

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,717 in reported general payments places this provider in the 85th percentile of 354 critical care medicine providers in Pennsylvania.

See all critical care medicine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$13,219
Medicare patients
35
Services billed
74

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other critical care medicine in Pittsburgh

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →